Search research articles
Contact Us
Filters
Showing results (101-110 of 145) with videos related to
Page
of 15
Sort By:
NPJ Vaccines
|
June 19, 2021
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
Katherine L Mallory, Justin A Taylor, Xiaoyan Zou, et al.
Molecular Therapy. Nucleic Acids
|
April 12, 2019
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
Norbert Pardi, Celia C LaBranche, Guido Ferrari, et al.
Frontiers in Immunology
|
December 24, 2025
Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations
Clauvis Kunkeng Yengo, Xiaomei Liu, Gabriel Laghlali, et al.
The Journal of Clinical Investigation
|
October 7, 2021
Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
Sita Awasthi, James J Knox, Angela Desmond, et al.
Cell Stem Cell
|
November 29, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
Fatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
Science (New York, N.Y.)
|
November 24, 2022
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Claudia P Arevalo, Marcus J Bolton, Valerie Le Sage, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 12, 2024
mRNA-LNP vaccine-induced CD8<sup>+</sup> T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R Melo-Silva, Lingjuan Tang, et al.
Immunity
|
December 9, 2020
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
Katlyn Lederer, Diana Castaño, Daniela Gómez Atria, et al.
Science Translational Medicine
|
May 13, 2026
RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I
András Tálas, Eleonora I Ioannidi, Yanik Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 26, 2024
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire
Evan R Abt, Alex K Lam, Miyako Noguchi, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 145) with videos related to
Sort By:
Page
of 15
NPJ Vaccines
|
June 19, 2021
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
Katherine L Mallory, Justin A Taylor, Xiaoyan Zou, et al.
Molecular Therapy. Nucleic Acids
|
April 12, 2019
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
Norbert Pardi, Celia C LaBranche, Guido Ferrari, et al.
Frontiers in Immunology
|
December 24, 2025
Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations
Clauvis Kunkeng Yengo, Xiaomei Liu, Gabriel Laghlali, et al.
The Journal of Clinical Investigation
|
October 7, 2021
Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
Sita Awasthi, James J Knox, Angela Desmond, et al.
Cell Stem Cell
|
November 29, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
Fatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
Science (New York, N.Y.)
|
November 24, 2022
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Claudia P Arevalo, Marcus J Bolton, Valerie Le Sage, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 12, 2024
mRNA-LNP vaccine-induced CD8<sup>+</sup> T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R Melo-Silva, Lingjuan Tang, et al.
Immunity
|
December 9, 2020
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
Katlyn Lederer, Diana Castaño, Daniela Gómez Atria, et al.
Science Translational Medicine
|
May 13, 2026
RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I
András Tálas, Eleonora I Ioannidi, Yanik Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 26, 2024
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire
Evan R Abt, Alex K Lam, Miyako Noguchi, et al.
Page
of 15